Small, but noticeable C-terminal alternative isoforms expression differences across GTEx tissue types coupled with our observation that TP53 C-terminal alternative isoforms expression cannot be reliably selected for during tumor progression hints at the possibility that function of TP53 C-terminal alternative isoforms may lay in fine tuning TP53 activity. The gene discussed is TP53; the disease is neoplasm.